DCT

1:19-cv-02317

Allergan USA Inc v. Aurobindo Pharma Ltd

General

Filed

12/20/19

Cause of ActionWillful Patent Infringement

SectorBiotech

Status

Closed (05/20/22)

Patent Owner

NPE (W)

SourcePACER

Judge	Period	PO Win Rate
Richard G. Andrews	12/26/19 - 06/01/22	35%

Plaintiff

Party

Name	Ratings
Allergan USA Inc	L5E
Allergan Sales LLC NPE	L5E
Allergan Pharmaceuticals Intl Ltd	L5E
Gedeon Richter PLC	---- --

Attorney

Name	Ratings
Morris Nichols Arsht & Tunnell LLPLocal	L5A
Jack B. Blumenfeld	L5A
Jeremy A. Tigan	L5C
Covington & Burling LLP	L4B
Eric R. Sonnenschein	L5A
Jeffrey B. Elikan	L5A
Christopher N. Sipes	L5C
Erica N. Andersen	L4B
Chanson Chang	L4C
Alexander Trzeciak	L2C
Melissa Keech	---- --

Defendant

Party

Name	Ratings
Aurobindo Pharma USA Inc	L4E
Sun Pharmaceutical Industries Ltd	L5E
Sun Pharma Global FZE	L5E
Zydus Pharmaceuticals USA Inc	L4E
Zydus Lifesciences Ltd	L4E

Attorney

Name	Ratings
Locke Lord LLP	L5A
David B. Abramowitz	L5B
Michael J. Gaertner	L5D
Timothy F. Peterson	L4D
Carolyn A. Blessing	L4D
August Melcher	L2B
Jonathan B. Turpin	L2C
Richards Layton & Finger PALocal	L5D
Kelly E. Farnan	L5E
Young Conaway Stargatt & Taylor LLPLocal	L5E
Pilar G. Kraman	L5B
Beth Ann Swadley	L2E
Morris James LLPLocal	L4E
Kenneth L. Dorsney	L5E
Katten Muchin Rosenman LLP	L3C
Brian J. Sodikoff	L5C
Matthew M. Holub	L5D
Christopher B. Ferenc	L4D
Kratz Barry LLP	L1E
Timothy H. Kratz	L5E
George J. Barry, III	L5E
Michael P. Hogan	L4E
R. Touhey Myer	L3E